Reuters
Search documents
EU approves higher dose of Novo's Wegovy
Reuters· 2026-02-17 14:09
EU approves higher dose of Novo's Wegovy | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo [Purchase Licensing Rights, opens new tab]- Companies[Novo Nordisk A/S]FollowFeb 17 (Reuters) - The European Commission has approved a higher dose of Novo Nordisk's [(NOVOb.CO), opens new tab] popular weight- ...
EU says no short-term oil supply risk in Hungary, Slovakia
Reuters· 2026-02-17 14:03
Core Viewpoint - The European Commission has stated that there is no short-term risk to the security of oil supplies in Hungary and Slovakia despite disruptions in Russian oil flows due to a Ukrainian pipeline attack [1] Group 1: Oil Supply Security - The European Commission confirmed that both Hungary and Slovakia have sufficient emergency stocks, holding 90 days' worth of reserves, which mitigates short-term supply risks [1] - The disruption in oil flows is attributed to a Russian attack on a Ukrainian pipeline, which has halted supplies since January 27 [1] Group 2: Hungary's Response - In response to the supply disruption, Hungary is seeking to import Russian crude oil via Croatia's Adria pipeline, utilizing an emergency exemption from EU sanctions [1] - Croatia's economy minister has indicated that while the Adria pipeline can accommodate more oil imports, it should not come from Russia due to the implications of funding the conflict in Ukraine [1] Group 3: Regulatory Context - EU regulations require member states to maintain 90 days' worth of net oil imports as a buffer against supply shocks, which Hungary and Slovakia currently meet [1] - Seaborne imports of Russian crude are banned under EU sanctions, but landlocked countries can claim exemptions if their pipeline supplies are interrupted [1]
Disc Medicine to pursue traditional U.S. approval after FDA rejects new fast-track route
Reuters· 2026-02-17 13:43
Disc to pursue traditional U.S. approval for bitopertin after FDA rejects new fast-track route | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly//File Photo [Purchase Licensing Rights, opens new tab]- Companies[Disc Medicine Inc]FollowFeb 17 (Reuters) - Disc Medicine [(IRON.O), opens new t ...
Enagas open to European regulated asset deals aligned with hydrogen-focused strategy, CEO says
Reuters· 2026-02-17 13:17
Enagas open to European regulated asset deals aligned with hydrogen-focused strategy, CEO says | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Enagas CEO Arturo Gonzalo speaks at Zona Franca near Barcelona, Spain February 2, 2023. REUTERS/Albert Gea/File Photo [Purchase Licensing Rights, opens new tab]- Companies[Enagas SA]FollowMADRID, Feb 17 (Reuters) - Spain's Enagas [(ENAG.MC), opens new tab] is open to acquiring regulated ener ...
Danaher to buy Masimo for $9.9 billion
Reuters· 2026-02-17 13:04
Danaher will acquire pulse oximeter maker Masimo for $9.9 billion, the company said on Tuesday, as the contract research firm looks to bulk up its diagnostics portfolio. ...
Labcorp forecasts upbeat annual profit on strong demand for diagnostic products
Reuters· 2026-02-17 12:59
Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, banking on robust demand for its diagnostic tests. ...
Air India, Germany's Lufthansa tie up to grow passenger traffic
Reuters· 2026-02-17 12:58
Core Insights - Air India and Lufthansa are collaborating to increase passenger traffic between India and Europe, leveraging the recent India-EU free trade agreement [1] - The initial focus will be on enhancing traffic between India and Lufthansa's key markets, including Germany, Austria, Belgium, Italy, and Switzerland, with plans to expand to the rest of Europe and the Indian subcontinent [1] - The partnership will involve codesharing on 145 routes across 15 Indian cities and 29 European cities, covering 20 countries [1] - A comprehensive joint business agreement will be established, pending regulatory approvals [1] - Air India has also entered a cooperation framework with Singapore Airlines to enhance route offerings and collaboration [1]
Trading platform eToro beats profit estimates on growth across asset classes
Reuters· 2026-02-17 12:54
Core Insights - eToro exceeded profit estimates for Q4, driven by growth across various asset classes, with shares rising approximately 8.9% pre-market [1] - The company's assets under administration increased by 11% year-on-year to $18.5 billion, indicating strong performance in its multi-asset business model [1] - Despite the positive overall results, net contribution fell by 10% to $227 million, reflecting challenges in the crypto market [1] Financial Performance - eToro reported an adjusted profit of 71 cents per share for the three months ending December 31, surpassing analysts' average estimate of 63 cents per share [1] - The growth in U.S. equity markets during the quarter was supported by interest-rate cuts, although crypto market volatility raised caution among investors [1] Market Context - The emergence of new fintech firms is challenging traditional Wall Street institutions by attracting younger investors with lower trading costs and user-friendly platforms [1] - Concerns about a potential bubble in the market have arisen due to high valuations in select AI-linked stocks [1]
Leidos misses quarterly revenue estimates on government shutdown impact
Reuters· 2026-02-17 12:31
Core Viewpoint - Leidos Holdings reported fourth-quarter revenue below Wall Street estimates due to the impact of a six-week U.S. government shutdown, which disrupted operations and orders for defense contractors [1] Financial Performance - Leidos' fourth-quarter revenue was $4.21 billion, a decrease of 3.6% from the previous year and lower than analysts' expectations of $4.31 billion [1] - The company's adjusted profit per share for the fourth quarter was $2.76, exceeding expectations of $2.61, aided by a 160-basis point expansion in adjusted core profit margin and improved cost controls [1] Segment Performance - The health and civil segment, which provides electronic health record systems to the Department of Defense and Veteran Affairs hospitals, experienced a 9.3% drop in sales [1] Future Outlook - Leidos forecasted 2026 adjusted profit per share to be between $12.05 and $12.45, with the midpoint being 4 cents lower than analysts' estimates of $12.29 [1]
Activist investor Jana Partners builds stake in Fiserv, WSJ reports
Reuters· 2026-02-17 12:15
Activist investor Jana Partners builds stake in Fiserv, WSJ reports | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[Fiserv Inc]FollowFeb 17 (Reuters) - Activist investor Jana Partners has built a stake in Fiserv [(FISV.O), opens new tab] and is pressing the payments company to pursue steps to lift its lagging share price, the Wall Street journal reported on Tuesday.Shares of the company were up 6.5% in premarket trading ...